StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report released on Tuesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Performance The company has a market cap of $833,000.00, a price-to-earnings ratio of -0.01 and a beta of -0.90. Athersys has a 12 […]

Analysts at StockNews.com started coverage on shares of BioLineRx (NASDAQ:BLRX – Get Free Report) in a report issued on Thursday. The brokerage set a “hold” rating on the biotechnology company’s stock. BioLineRx Stock Performance BLRX opened at $0.43 on Thursday. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.49 and a […]

StockNews.com started coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a report published on Tuesday. The firm issued a hold rating on the biopharmaceutical company’s stock. FibroGen Stock Performance Shares of FGEN stock opened at $0.32 on Tuesday. The stock’s 50-day moving average is $0.37 and its two-hundred day moving average is $0.77. […]